Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-adrenergic receptors, or alpha-adrenoceptors, are a class of G protein-coupled receptors that mediate the effects of the endogenous catecholamines epinephrine and norepinephrine. They are divided into two main types: alpha-1 and alpha-2, each with further subtypes (alpha-1A, 1B, 1D and alpha-2A, 2B, 2C) [StatPearls, 2023]. Alpha-1 receptors are predominantly located on vascular smooth muscle and the prostate, where their activation leads to vasoconstriction and muscle contraction [NIH, 2022]. In contrast, alpha-2 receptors are often found presynaptically, where they act as autoreceptors to inhibit the further release of norepinephrine, providing a feedback loop for the sympathetic nervous system [PubMed, 2021]. Therapeutically, alpha-1 antagonists like tamsulosin are used to treat benign prostatic hyperplasia, while alpha-1 agonists like phenylephrine serve as decongestants [PubChem, 2024]. Alpha-2 agonists such as clonidine are utilized for hypertension and ADHD management due to their central sympatholytic effects [StatPearls, 2023]. Understanding the distribution and signaling pathways of these receptors is critical for managing cardiovascular and urological conditions.
Alpha-adrenergic receptors function as G protein-coupled receptors that respond to endogenous catecholamines. Alpha-1 receptors primarily couple to Gq proteins, activating phospholipase C to increase intracellular calcium and induce smooth muscle contraction. Alpha-2 receptors primarily couple to Gi proteins, inhibiting adenylyl cyclase to decrease cAMP levels and modulate neurotransmitter release.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-adrenergic receptor (Alpha-AR) (Alpha-AR).